PierianDX fetches $27 mln Series B
St. Louis-based PierianDx, a clinical genomics informatics company, has raised $27 million in Series B funding. ATW Partners and SJF Ventures led the round with participation from other investors that included Health Catalyst Capital, Inova Health Systems, RTI International and ARUP Laboratories.
29 October 2019•1 min read
